Table 2. Raman-CRC model performance for different cancer stages versus FIT
Sensitivity for UICC guidance stages
StageIIIIIIIV
Raman-CRC50% (n = 4)90% (n = 10)100% (n = 12)100% (n = 3)
FIT27 73% (65%–79%)80% (74%–84%)82% (77%–87%)79% (70%–86%)
  • CRC = colorectal cancer. FIT = faecal immunochemical test.